Get started
Author

Haritha Gandicheruvu

Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study
2023 · David Marti-Aguado, Amir Gougol, et al. · EClinicalMedicine · 18
PDF
Impact of CD34+ graft cell dose on acute GVHD and engraftment in matched sibling donor peripheral blood stem cell transplantation with post-transplant cyclophosphamide prophylaxis: a CIBMTR analysis
2026 · Moazzam Shahzad, Muhammad Kashif Amin, et al. · Bone Marrow Transplantation
PDF
Efficacy-toxicity paradox of perioperative immune checkpoint inhibitors: An ESMO-MCBS v2.0 quality analysis of FDA approvals.
2026 · Haritha Gandicheruvu, Abhenil Mittal, et al. · JCO Oncology Practice
Surrogacy between event-free survival and overall survival in perioperative immunotherapy trials.
2026 · Haritha Gandicheruvu, Abhenil Mittal, et al. · JCO Oncology Practice
PDF
MM-561: Dual-Target CAR-T and in Vivo Platforms in Relapsed/Refractory Multiple Myeloma: A Systematic Scoping Review of Efficacy, Toxicity, and Access
2026 · Manpreet Saini, Haritha Gandicheruvu, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
2026 · Manpreet Saini, Tamara Al-Naimi, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MM-1669: Population-Level Trends in Sepsis-Related Mortality Among Patients With Multiple Myeloma: Insights From CDC WONDER
2026 · Amna Bint I Munir, Neha Singh, et al. · Clinical Lymphoma Myeloma & Leukemia
MDS-1034: Cooperative Effects of U2AF1-S34 and BCOR Mutations in Myeloid Neoplasms
2026 · Akram Abushamma, Zachary Brady, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-660: High Specificity but Limited Sensitivity: Is the Khorana Score Sufficient as a Stand-Alone Tool to Guide Thromboprophylaxis in Contemporary Oncological Practice
2026 · Manpreet Saini, Tamara Al-Naimi, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MDS-1034: Cooperative Effects of U2AF1-S34 and BCOR Mutations in Myeloid Neoplasms
2026 · Akram Abushamma, Zachary Brady, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-1669: Population-Level Trends in Sepsis-Related Mortality Among Patients With Multiple Myeloma: Insights From CDC WONDER
2026 · Amna Bint IMunir, Neha Singh, et al. · Clinical Lymphoma Myeloma & Leukemia
Comparative toxicity profile of chimeric antigen receptor T-cell therapy versus bispecific T-cell engagers in multiple myeloma and B-cell lymphomas: A propensity-matched real-world analysis.
2026 · Amna Bint I Munir, Sapna Kumari, et al. · Journal of Clinical Oncology
Efficacy and patient-reported outcome of trophoblast cell surface antigen-2 antibody-drug conjugate in advanced non–small cell lung cancer: An individual patient data survival analysis and meta-analysis.
2026 · Mahnoor Sukaina, Haritha Gandicheruvu, et al. · Journal of Clinical Oncology
Impact of cirrhosis on the metabolic profile, tumor presentation, and management of MASLD-associated hepatocellular carcinoma: A systematic review and meta-analysis.
2026 · Haritha Gandicheruvu, Mahnoor Sukaina, et al. · Journal of Clinical Oncology
PDF
Hematologic and cardiovascular outcomes of SGLT2 inhibitors in patients with chronic lymphocytic leukemia and type 2 diabetes: A real-world TriNetX analysis.
2026 · Safa Saadat Afridi, Sai Sushrutha Mudupula Vemula, et al. · Journal of Clinical Oncology
Inpatient palliative care utilization and outcomes among decedent patients with metastatic cancer in the U.S.
2026 · Jiazhang Xing, Folajimi J. Atunde, et al. · Journal of Clinical Oncology
Rethinking the role of tumor size in bladder preservation: Comparing survival outcomes of radical cystectomy (RC) and tri-modality therapy (TMT).
2026 · Dawood Hasan Syed, Haritha Gandicheruvu, et al. · Journal of Clinical Oncology
Steroid Therapy in Community-Acquired Pneumonia: An Updated Systematic Review and Meta-Analysis
2026 · Bijeta Keisham, Sanchit Duhan, et al. · Heart & Lung
PDF
Impact of CD34+ Graft Cell Dose on Outcomes after Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis
2026 · Moazzam Shahzad, Muhammad Kashif Amin, et al. · Transplantation and Cellular Therapy
Su2116 PREDICTORS OF HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC PATIENTS WITH METABOLIC ASSOCIATED-STEATOTIC LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
2026 · Shruti Sandeep Jain, Muzna Rehman, et al. · Gastrointestinal Endoscopy
Su2116 PREDICTORS OF HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC PATIENTS WITH METABOLIC ASSOCIATED-STEATOTIC LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
2026 · Shruti Sandeep Jain, Muzna Rehman, et al. · Gastroenterology
Skeletal-related event impact on prostate cancer mortality in the older population in the US: A 24-year trend regression analysis.
2026 · Mahnoor Sukaina, Arindam Bagga, et al. · Journal of Clinical Oncology
Safety and Efficacy of Consolidation-Phase Blinatumomab in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia: A Systematic Review and Meta-analysis
2026 · Yagnapriya Ammakola, Chandra Kakarala, et al. · International Journal of Cancer Care and Delivery
Title: Achieving Minimal Residual Disease (MRD) Negativity during the Disease Course in relapsed/refractory Multiple Myeloma (RRMM): Implications for Treatment and Transplant Strategies
2026 · Ali Awada, Amjad Alguraan, et al. · Transplantation and Cellular Therapy
Sustained Minimal Residual Disease (MRD) Negativity for ≥1 Year in Transplant Eligible Newly Diagnosed Multiple Myeloma (NDMM): A Systematic Review of Prospective Clinical Trials
2026 · Ali Awada, Amjad Alguraan, et al. · Transplantation and Cellular Therapy
Works count: 29
Citation count: 18
H-index: 1
I10-index: 1
Year
Topic
Type